Home
Focus Areas
About Us
The FDA's Breakthrough Therapy Designation (BTD) program can reduce the time to market for critical drugs while maintaining safety standards.
The BTD program is designed to expedite the development of drugs targeting serious conditions for which there are not yet effective medical treatments.
While accelerating the time it takes to get drugs to market can save lives, it also raises questions about unintended consequences, particularly regarding the quality and safety of approved therapies.
Selected Grant News Headlines
A customized collection of grant news from foundations and the federal government from around the Web.
Rad AI announces an additional $8 million investment led by four health systems.Advocate Health, Memorial Hermann Health System, Corewell Health, and Atlantic Health System lead the investment.Rad AI...more
Abe Sutton, the new director of the Center for Medicare and Medicaid Innovation, has begun to set a new course for the CMS Innovation Center.Sutton: "All of the pillars really build on prevention,...more
Indianapolis philanthropists Sarah and John Lechleiter and Deborah and Randall Tobias have committed $20 million to establish the Tobias-Lechleiter Institute for Clinical Innovation.The gift, the...more
HCA Healthcare commits $5 million to Belmont University's Thomas F.Massey College of Medicine program.Students will have the opportunity to complete clinical rotations at HCA Healthcare's TriStar...more
EVERSANA, a leading provider of commercial services to the life sciences industry, announces new appointments to its global agency network.Angela Tenuta has been named Global Group President,...more
German biopharmaceutical company BioNTech announces landmark investment of up to 1 billion in the UK over the next decade.The move, supported by up to 129 million in government funding, represents...more
Cleveland Clinic London has launched the Exploring Health with Cleveland Clinic London podcast.It is hosted by Mr Kash Akhtar, a leading consultant orthopaedic knee surgeon.The podcast sees Mr Akhtar...more
Asthma home visiting is an evidence-based intervention proven to improve health outcomes, lower healthcare utilization costs and improve patient care.This report explores the different approaches and...more
Abundant Venture Partners Launches Venture Growth Platform.ChristianaCare, Kettering Health, Medical University of South Carolina, Lurie Children's Hospital of Chicago, MedStar Health, Sharp...more
PAHO Advances Discussion on Regional Strategies for Innovation and Production of Health Technologies at the 2025 World Local Production Forum - PAHO/WHO | Pan American Health Organization.The panel...more
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.
